Intellia Therapeutics Inc buy BMO Capital Markets
Start price
13.03.23
/
50%
€36.37
Target price
13.03.24
-
Performance (%)
-27.88%
End price
14.03.24
€26.23
Summary
This prediction ended on 14.03.24 with a price of €26.23. The prediction for Intellia Therapeutics Inc disappointed with a performance of -27.88%. BMO_Capital_Markets has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 5.857% | 5.857% | -35.535% |
| iShares Core DAX® | 1.280% | 1.320% | 13.605% |
| iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% |
| iShares Nikkei 225® | -2.006% | -1.389% | 8.973% |
| iShares S&P 500 | -0.662% | -1.884% | 23.684% |
Comments by BMO_Capital_Markets for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€58.01
10.11.24
10.11.24
8.06%
26.07.24
26.07.24
Stopped prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.72
10.05.24
10.05.24
€64.98
10.05.25
10.05.25
7.39%
26.07.24
26.07.24